US20010031246A1 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- US20010031246A1 US20010031246A1 US09/805,524 US80552401A US2001031246A1 US 20010031246 A1 US20010031246 A1 US 20010031246A1 US 80552401 A US80552401 A US 80552401A US 2001031246 A1 US2001031246 A1 US 2001031246A1
- Authority
- US
- United States
- Prior art keywords
- oral composition
- sodium
- hydroxypropiophenone
- wintergreen
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
Definitions
- the present invention relates to an oral composition comprising 2′-hydroxypropiophenone.
- flavours used in oral care formulations are mint. Further, there are many different flavour ingredients which effect several different minty flavours to the consumer, for example, peppermint oil, spearmint oil and wintergreen oil to name a few. Wintergreen oil is a particularly popular flavour material and is commonly used in oral care formulations, particularly toothpastes, all over the world.
- the present invention provides an oral composition according to claim 1 .
- the pH of the composition is alkaline. By this is meant that it is not neutral, or substantially neutral, and ranges from about 7.5 to about 12.
- the pH is greater than 7.5 and preferably above 8.5.
- the oral composition according to the invention typically comprises from 0.0001 to 1% by weight 2′-hydroxypropiophenone, preferably from 0.001 to 0.75% and especially from 0.1 to 0.2% by weight.
- the invention relates to a use of 2′-hydroxypropiophenone according to claim 6 .
- the oral composition according to the invention typically comprises further ingredients which are common in the art, such as:
- antimicrobial agents e.g. Triclosan, chlorhexidine, copper- , zinc- and stannous salts such as zinc citrate, zinc sulphate, zinc glycinate, sodium zinc citrate and stannous pyrophosphate, sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride; bis-guanides, such as chlorhexidine digluconate, hexetidine, octenidine, alexidine; and halogenated bisphenolic compounds, such as 2,2′ methylenebis-(4-chloro-6-bromophenol);
- anti-inflammatory agents such as ibuprofen, flurbiprofen, aspirin, indomethacin etc.
- anti-caries agents such as sodium- and stannous fluoride, aminefluorides, sodium monofluorophosphate, sodium trimeta phosphate and casein;
- plaque buffers such as urea, calcium lactate, calcium glycerophosphate and strontium polyacrylates; vitamins such as Vitamins A, C and E;
- desensitising agents e.g. potassium citrate, potassium chloride, potassium tartrate, potassium bicarbonate, potassium oxalate, potassium nitrate and strontium salts;
- anti-calculus agents e.g. alkali-metal pyrophosphates, hypophosphite-containing polymers, organic phosphonates and phosphocitrates etc.;
- biomolecules e.g. bacteriocins, antibodies, enzymes, etc.
- flavours e.g. peppermint and spearmint oils
- preservatives e.g. methyl paraben
- opacifying agents e.g. titanium dioxide
- colouring agents e.g. FD&C Blue No. 1, FD&C Yellow No. 5;
- pH-adjusting agents e.g. monosodium phosphate, trisodium phosphate, sodium hydroxide, sodium carbonate
- sweetening agents e.g. sodium saccharin, aspartame
- pharmaceutically acceptable carriers e.g. starch, sucrose, water or water/alcohol systems etc.
- surfactants such as anionic, nonionic, cationic and zwitterionic or amphoteric surfactants
- particulate abrasive materials such as silicas, aluminas, calcium carbonates, dicalciumphosphates, calcium pyrophosphates, hydroxyapatites, trimetaphosphates, insoluble hexametaphosphates and so on, including agglomerated particulate abrasive materials, usually in amounts between 3 and 60% by weight of the oral care composition.
- humectants such as glycerol, sorbitol, propyleneglycol, xylitol, lactitol etc.;
- binders and thickeners such as sodium carboxymethyl- cellulose, xanthan gum, gum arabic etc. as well as synthetic polymers such as polyacrylates and carboxyvinyl polymers such as Carbopol®;
- polymeric compounds which can enhance the delivery of active ingredients such as antimicrobial agents can also be included.
- examples of such polymers are copolymers of polyvinylmethylether with maleic anhydride and other similar delivery enhancing polymers, e.g. those described in DE-A-3,942,643 (Colgate);
- bleaching agents such as peroxy compounds e.g. potassium peroxydiphosphate, effervescing systems such as sodium bicarbonate/citric acid systems, colour change systems, and so on.
- Liposomes may also be used to improve delivery or stability of active ingredients.
- the oral compositions may be in any form common in the art, e.g. toothpaste, gel, mousse, aerosol, gum, lozenge, powder, cream, etc. and may also be formulated into systems for use in dual-compartment type dispensers.
- EXAMPLE 1 Percent by Weight Calcium carbonate 40.00 Sorbitol 27.00 Hydrated silica 2.00 Sodium carboxymethyl cellulose 0.90 Sodium lauryl sulphate 2.00 Titanium dioxide 1.00 Sodium monofluorophosphate 0.80 Trisodium phosphate 0.50 Sodium saccharin 0.20
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Oral composition comprises a wintergreen flavour imparting ingredient and having an alkaline pH, wherein the wintergreen flavour imparting ingredient is 2′-hydroxypropiophenone.
Description
- The present invention relates to an oral composition comprising 2′-hydroxypropiophenone.
- One of the commonest flavours used in oral care formulations is mint. Further, there are many different flavour ingredients which effect several different minty flavours to the consumer, for example, peppermint oil, spearmint oil and wintergreen oil to name a few. Wintergreen oil is a particularly popular flavour material and is commonly used in oral care formulations, particularly toothpastes, all over the world.
- The flavour molecules which are usually used to impart a wintergreen flavour to such oral compositions are only ever used in toothpastes which have a substantially neutral pH, for example, the paste marketed by the applicant under the brand name “Close-up®”.
- It is well known in toothpaste manufacture that the main ingredient in wintergreen flavour, methyl salicylate, is unstable in alkaline pH ranges.
- This presents a problem since some of the more popular oral care compositions are at a substantially alkaline pH. For example, bicarbonate toothpastes are marketed by many of the oral care consumer products suppliers and are only ever made at substantially alkaline pH ranges. Further, where calcium carbonate is used as a polishing agent, for example, in the developing and emerging markets, the general pH of a formulation is also substantially alkaline, often as high as 10.
- The prior art literature also refers to wintergreen oil as a flavour ingredient. WO 98/31242 (Wrigley) discloses the use of 2′-hydroxypropiophenone as a substitute for the major wintergreen ingredient methyl salicylate. However, no mention is made of the fact that 2′-hydroxypropiophenone can also be used to overcome the disadvantages of methyl salicylate as a wintergreen flavour ingredient where the pH is alkaline.
- It is an object of the invention to provide an oral composition which is stable, has a wintergreen flavour and is at an alkaline pH.
- Accordingly, the present invention provides an oral composition according to claim 1.
- 2′-hydroxypropiophenone is commercially available from Sigma-Aldrich Company Ltd., The Old Brickyard, Gillingham, Dorset SP12 4XT, United Kingdom. A synthesis for the compound may be found in Org. Synth. 13, 90 (1933).
- It is an essential feature of the invention that the pH of the composition is alkaline. By this is meant that it is not neutral, or substantially neutral, and ranges from about 7.5 to about 12.
- In a particular embodiment the pH is greater than 7.5 and preferably above 8.5.
- The oral composition according to the invention typically comprises from 0.0001 to 1% by weight 2′-hydroxypropiophenone, preferably from 0.001 to 0.75% and especially from 0.1 to 0.2% by weight.
- In a further aspect the invention relates to a use of 2′-hydroxypropiophenone according to claim 6.
- The oral composition according to the invention typically comprises further ingredients which are common in the art, such as:
- antimicrobial agents, e.g. Triclosan, chlorhexidine, copper- , zinc- and stannous salts such as zinc citrate, zinc sulphate, zinc glycinate, sodium zinc citrate and stannous pyrophosphate, sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride; bis-guanides, such as chlorhexidine digluconate, hexetidine, octenidine, alexidine; and halogenated bisphenolic compounds, such as 2,2′ methylenebis-(4-chloro-6-bromophenol);
- anti-inflammatory agents such as ibuprofen, flurbiprofen, aspirin, indomethacin etc.;
- anti-caries agents such as sodium- and stannous fluoride, aminefluorides, sodium monofluorophosphate, sodium trimeta phosphate and casein;
- plaque buffers such as urea, calcium lactate, calcium glycerophosphate and strontium polyacrylates; vitamins such as Vitamins A, C and E;
- plant extracts;
- desensitising agents, e.g. potassium citrate, potassium chloride, potassium tartrate, potassium bicarbonate, potassium oxalate, potassium nitrate and strontium salts;
- anti-calculus agents, e.g. alkali-metal pyrophosphates, hypophosphite-containing polymers, organic phosphonates and phosphocitrates etc.;
- biomolecules, e.g. bacteriocins, antibodies, enzymes, etc.;
- flavours, e.g. peppermint and spearmint oils;
- other proteinaceous materials such as collagen;
- preservatives; e.g. methyl paraben;
- opacifying agents; e.g. titanium dioxide;
- colouring agents; e.g. FD&C Blue No. 1, FD&C Yellow No. 5;
- pH-adjusting agents; e.g. monosodium phosphate, trisodium phosphate, sodium hydroxide, sodium carbonate
- sweetening agents; e.g. sodium saccharin, aspartame
- pharmaceutically acceptable carriers, e.g. starch, sucrose, water or water/alcohol systems etc.;
- surfactants, such as anionic, nonionic, cationic and zwitterionic or amphoteric surfactants;
- particulate abrasive materials such as silicas, aluminas, calcium carbonates, dicalciumphosphates, calcium pyrophosphates, hydroxyapatites, trimetaphosphates, insoluble hexametaphosphates and so on, including agglomerated particulate abrasive materials, usually in amounts between 3 and 60% by weight of the oral care composition.
- humectants such as glycerol, sorbitol, propyleneglycol, xylitol, lactitol etc.;
- binders and thickeners such as sodium carboxymethyl- cellulose, xanthan gum, gum arabic etc. as well as synthetic polymers such as polyacrylates and carboxyvinyl polymers such as Carbopol®;
- polymeric compounds which can enhance the delivery of active ingredients such as antimicrobial agents can also be included. Examples of such polymers are copolymers of polyvinylmethylether with maleic anhydride and other similar delivery enhancing polymers, e.g. those described in DE-A-3,942,643 (Colgate);
- buffers and salts to buffer the pH and ionic strength of the oral care composition; and
- other optional ingredients that may be included are e.g. bleaching agents such as peroxy compounds e.g. potassium peroxydiphosphate, effervescing systems such as sodium bicarbonate/citric acid systems, colour change systems, and so on.
- Liposomes may also be used to improve delivery or stability of active ingredients.
- The oral compositions may be in any form common in the art, e.g. toothpaste, gel, mousse, aerosol, gum, lozenge, powder, cream, etc. and may also be formulated into systems for use in dual-compartment type dispensers.
- Particular embodiments according to the invention are illustrated with the following non-limiting examples:
EXAMPLE 1 Percent by Weight Calcium carbonate 40.00 Sorbitol 27.00 Hydrated silica 2.00 Sodium carboxymethyl cellulose 0.90 Sodium lauryl sulphate 2.00 Titanium dioxide 1.00 Sodium monofluorophosphate 0.80 Trisodium phosphate 0.50 Sodium saccharin 0.20 Flavour oil comprising 2′-hydroxypropiophenone 1.20 Water 24.40 pH = 9.7 -
EXAMPLE 2 Percent by Weight Hydrated silica 18.50 Sorbitol 45.00 Polyethylene glycol 5.00 Sodium carboxymethyl cellulose 0.90 Sodium lauryl sulphate 1.50 Titanium dioxide 1.00 Sodium bicarbonate 5.00 Sodium fluoride 0.22 Sodium saccharin 0.50 Flavour oil comprising 2′-hydroxypropiophenone 1.00 Water 21.38 pH = 9.1
Claims (6)
1. Oral composition comprising a wintergreen flavour imparting ingredient and having an alkaline pH, characterised in that the wintergreen flavour imparting ingredient is 2′-hydroxypropiophenone.
2. Oral composition according to , wherein it has a pH greater than 7.5.
claim 1
3. Oral composition according to , wherein it has a pH greater than 8.5.
claim 1
4. Oral composition according to , wherein it comprises as a polishing agent calcium carbonate.
claim 1
5. Oral composition according to , wherein it comprises sodium bicarbonate.
claim 1
6. Use of 2′-hydroxypropiophenone as a wintergreen flavour imparting ingredient in a composition according to any preceding claim.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP002302065.8 | 2000-03-14 | ||
| EP00302065 | 2000-03-14 | ||
| EP00302065 | 2000-03-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20010031246A1 true US20010031246A1 (en) | 2001-10-18 |
| US6436371B2 US6436371B2 (en) | 2002-08-20 |
Family
ID=8172792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/805,524 Expired - Lifetime US6436371B2 (en) | 2000-03-14 | 2001-03-13 | Oral composition |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6436371B2 (en) |
| EP (1) | EP1263401B1 (en) |
| CN (1) | CN1188106C (en) |
| AT (1) | ATE305291T1 (en) |
| AU (1) | AU2001242429A1 (en) |
| BR (1) | BR0109202A (en) |
| DE (1) | DE60113659T2 (en) |
| ES (1) | ES2249423T3 (en) |
| HU (1) | HU229034B1 (en) |
| PL (1) | PL200767B1 (en) |
| WO (1) | WO2001068044A1 (en) |
| ZA (1) | ZA200206309B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022160718A1 (en) * | 2021-01-28 | 2022-08-04 | 重庆登康口腔护理用品股份有限公司 | Anti-sensitive toothpaste capable of enhancing fluorine activity |
| WO2026017721A1 (en) * | 2024-07-19 | 2026-01-22 | Givaudan Sa | Organic compounds |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020098264A1 (en) * | 1998-11-27 | 2002-07-25 | Cherukuri Subraman R. | Medicated chewing gum delivery system for nicotine |
| US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
| ATE360455T1 (en) * | 2003-11-12 | 2007-05-15 | Symrise Gmbh & Co Kg | MIXTURE WITH WINTERGREEN SMELL AND TASTE |
| CA2587077C (en) * | 2004-11-09 | 2014-03-25 | Discus Dental Impressions, Inc. | Dental whitening systems |
| US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
| CN103881421B (en) * | 2014-03-07 | 2015-07-22 | 江苏双乐化工颜料有限公司 | Nanometer surface modifier and preparation method and using method thereof |
| CN107444775B (en) * | 2016-05-18 | 2020-06-12 | 高露洁-棕榄公司 | Dentifrice package |
| GB202102675D0 (en) | 2021-02-25 | 2021-04-14 | Givaudan Sa | Methods of masking off-tastes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4844883A (en) * | 1987-01-20 | 1989-07-04 | Florasynth, Inc. | Stabilization of wintergreen flavor in chalk-based dentifrice and method |
| US5174990A (en) * | 1990-02-07 | 1992-12-29 | 7-L Corporation | Mouthrinse and method of preparation |
| WO1998031242A1 (en) * | 1997-01-15 | 1998-07-23 | Wm. Wrigley Jr. Company | Enhanced flavors using 2'-hydroxypropiophenone |
| MXPA01001977A (en) * | 1998-08-24 | 2005-07-25 | Unilever Nv | Toothpaste comprising fine and coarse calcium carbonate. |
-
2001
- 2001-02-22 CN CNB018061885A patent/CN1188106C/en not_active Expired - Fee Related
- 2001-02-22 BR BR0109202-2A patent/BR0109202A/en not_active Application Discontinuation
- 2001-02-22 WO PCT/EP2001/002002 patent/WO2001068044A1/en not_active Ceased
- 2001-02-22 ES ES01915286T patent/ES2249423T3/en not_active Expired - Lifetime
- 2001-02-22 HU HU0204539A patent/HU229034B1/en not_active IP Right Cessation
- 2001-02-22 DE DE60113659T patent/DE60113659T2/en not_active Expired - Lifetime
- 2001-02-22 AT AT01915286T patent/ATE305291T1/en not_active IP Right Cessation
- 2001-02-22 PL PL357560A patent/PL200767B1/en unknown
- 2001-02-22 EP EP01915286A patent/EP1263401B1/en not_active Expired - Lifetime
- 2001-02-22 AU AU2001242429A patent/AU2001242429A1/en not_active Abandoned
- 2001-03-13 US US09/805,524 patent/US6436371B2/en not_active Expired - Lifetime
-
2002
- 2002-08-07 ZA ZA200206309A patent/ZA200206309B/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022160718A1 (en) * | 2021-01-28 | 2022-08-04 | 重庆登康口腔护理用品股份有限公司 | Anti-sensitive toothpaste capable of enhancing fluorine activity |
| WO2026017721A1 (en) * | 2024-07-19 | 2026-01-22 | Givaudan Sa | Organic compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| PL200767B1 (en) | 2009-02-27 |
| HUP0204539A3 (en) | 2010-01-28 |
| US6436371B2 (en) | 2002-08-20 |
| CN1188106C (en) | 2005-02-09 |
| PL357560A1 (en) | 2004-07-26 |
| EP1263401A1 (en) | 2002-12-11 |
| ATE305291T1 (en) | 2005-10-15 |
| DE60113659D1 (en) | 2005-11-03 |
| ES2249423T3 (en) | 2006-04-01 |
| CN1416333A (en) | 2003-05-07 |
| ZA200206309B (en) | 2003-08-07 |
| WO2001068044A1 (en) | 2001-09-20 |
| BR0109202A (en) | 2002-12-17 |
| DE60113659T2 (en) | 2006-07-06 |
| HUP0204539A2 (en) | 2003-04-28 |
| EP1263401B1 (en) | 2005-09-28 |
| HU229034B1 (en) | 2013-07-29 |
| AU2001242429A1 (en) | 2001-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5500448A (en) | Recurrent aphthous ulcer treatment method | |
| US6475472B2 (en) | Oral bleaching composition | |
| EP1203575A2 (en) | Clear gel-type dentrifices | |
| US6436371B2 (en) | Oral composition | |
| US6355227B1 (en) | Oral composition | |
| US6602491B2 (en) | Composition containing alkylhydroxybenzoates | |
| US20030068283A1 (en) | Composition | |
| US20050063920A1 (en) | Oral composition | |
| EP1282392B1 (en) | Oral composition | |
| US6436372B2 (en) | Oral composition with abrasive mixture of chalk and carbide | |
| US20050063919A1 (en) | Oral composition | |
| US20030068282A1 (en) | Composition | |
| EP3955884B1 (en) | A personal care composition comprising piperlongumine and process for producing the composition | |
| US20030049210A1 (en) | Oral composition | |
| GB2395433A (en) | Oral compositions comprising a halogenated hydroxydiphenyl ether, eg triclosan, and a delivery enhancing agent, eg a parahydroxybenzoate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KILCULLEN, NEIL;REEL/FRAME:011870/0593 Effective date: 20010509 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| FPAY | Fee payment |
Year of fee payment: 12 |